New York Gov. Kathy Hochul Is Pushing A Tax That Could End Up Literally Costing The Lives Of Smokers

Key Concepts

• Nicotine Pouches: Oral products (e.g., ZYN) used as a tobacco-free alternative to cigarettes.
• Harm Reduction: The public health strategy of minimizing the negative consequences of addictive behaviors (e.g., switching from combustible cigarettes to non-combustible nicotine delivery).
• Excise Tax: A legislative tax on specific goods, which Governor Hochul proposes at 75% for nicotine pouches.
• FDA Marketing Authorization: The regulatory approval process confirming that specific products meet public health standards under the 2009 Family Smoking Prevention and Control Act.

The Proposed New York Excise Tax

Governor Kathy Hochul’s proposed state budget includes a 75% excise tax on nicotine pouches. Steve Forbes argues that this policy is fundamentally flawed, as it treats non-combustible nicotine products as equivalent to traditional cigarettes. The administration’s budget director defended this by stating, "We see it as a distinction without a difference," a claim Forbes characterizes as scientifically and logically bankrupt.

The Science of Harm Reduction

Forbes emphasizes a critical distinction between nicotine and the delivery mechanism of cigarettes:

• Nicotine vs. Toxins: While nicotine is addictive, it is described as "relatively harmless" in isolation. The lethal nature of cigarette smoking stems from the inhalation of numerous toxins and carcinogens produced by combustion.
• Comparative Efficacy: Forbes cites the United Kingdom’s public health approach, which actively advocates for vaping and nicotine alternatives as superior tools for smoking cessation compared to traditional methods like patches or gum.
• Non-Inhalation: Unlike cigarettes or vapes, nicotine pouches are placed between the lip and gum, eliminating the risks associated with inhaling smoke or vapor into the lungs.

Regulatory Standing and FDA Findings

The summary of the FDA’s position contradicts the state’s rationale for the tax. Near the end of the Biden administration, the FDA authorized the marketing of 20 ZYN nicotine pouch products, including 10 different flavors. The FDA’s determination was based on an "extensive scientific review," concluding that these products meet the public health standards required by the 2009 Family Smoking Prevention and Control Act.

Critical Arguments and Implications

• Public Distrust: Forbes argues that this tax proposal exacerbates the existing public distrust in government officials, a sentiment intensified by the handling of health policies during the pandemic.
• "Medical Malpractice": Forbes labels the tax a form of "medical malpractice." By artificially inflating the price of safer alternatives, the state may discourage smokers from switching to pouches.
• Public Health Risk: The core argument is that by making the safer alternative (pouches) prohibitively expensive, the government is effectively incentivizing the continued use of combustible cigarettes, thereby increasing the incidence of lung cancer and other tobacco-related diseases.

Conclusion

The main takeaway is that New York’s proposed 75% tax on nicotine pouches ignores established scientific distinctions between nicotine delivery systems and combustible tobacco. By disregarding FDA findings and the principles of harm reduction, the policy risks public health outcomes by creating a financial barrier to smoking cessation, ultimately undermining the credibility of state health authorities.